Postneoadjuvant adjuvant chemotherapy in resected N1 non-small cell lung cancer with residual nodal disease.

James W SmithyJoshua E RosenSarah J GaoAnthony W Kim

Published in: Journal of surgical oncology (2018)

This analysis suggests that adjuvant chemotherapy is not associated with increased survival in NSCLC patients with pathologic N1 NSCLC following neoadjuvant chemotherapy and resection.

Keyphrases

neoadjuvant chemotherapy
lymph node
small cell lung cancer
locally advanced
sentinel lymph node
advanced non small cell lung cancer
rectal cancer
radiation therapy
early stage
epidermal growth factor receptor
tyrosine kinase
data analysis